Bharat Biotech’s Covid-19 vaccine ‘Covaxin’ enters phase-3 trials
PTI, Nov 16, 2020, 4:10 PM IST
New Delhi: Covid-19 vaccine, Covaxin, being developed by Bharat Biotech is now undergoing phase-3 trials, Krishna Ella, Chairman and Managing Director, Bharat Biotech said on Monday.
Speaking virtually at a programme organised by the Indian School of Business, Ella said the company is also working on another vaccine for Covid-19 which would be in the form of nasal drops and can be ready by next year.
“We partnered with ICMR for Covid-19 vaccine as we speak it entered the phase 3 trials,” he said.
Bharat Biotech is the only vaccine company in the world which has BSL3 production facility (Biosafety level 3), he said.
Last month the vaccine maker said it had successfully completed interim analysis of Phase I and II trials of the vaccine and is initiating Phase-III trials in 26,000 participants.
Covaxinis being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV).
The city-based vaccine maker had on October 2 sought the Drug Controller General of India’s (DCGI) permission to conduct phase 3 randomised double-blind placebo-controlled multicentre trial of its Covid-19 vaccine, sources said.
“We are working on another vaccine through nasal drops my feeling is by next year it will reach the population,” Ella said.
Bharat Biotech in September said it entered into a licensing agreement with Washington University School of Medicine in St. Louis for a novel “chimp-adenovirus” (Chimpanzee adenovirus), single-dose intranasal vaccine for Covid-19.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
MP home minister directs DGP to file FIR against Amazon officials, owner
HC proposes to reduce costs on Juhi Chawla from Rs 20L to Rs 2L in 5G lawsuit
2007 obscenity case: Mumbai court calls Shilpa Shetty ‘victim’ of Richard Gere’s act, discharges her
Related Articles More
Low-cost smartphone-based test can accurately detect COVID-19 in 20 minutes
Don’t want people’s livelihood to be affected, Covid curbs to be eased as soon as possible: Kejriwal
Shocking! Woman vaccinated four months after her death
Breakthrough COVID-19 infections generate strong antibody response: Study
Karnataka reports over 50,000 COVID-19 cases
Jamaat-e-Islami Hind asks Muslim students not to participate in ‘Surya Namaskar’ on R-Day
EC ban on physical electioneering affects campaign material business
Mumbai records AQI 271; air quality severe in parts of city
HMSI launches 2022 CBR 650R at Rs 9.35 lakh
Fly-past of 75 aircraft, display of 10 scrolls to happen for first time at RDay parade: MoD